PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

brivaracetam vs cannabidiol

Side-by-side comparison of brivaracetam and cannabidiol Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.

Drug Class
brivaracetam Anticonvulsant (SV2A Ligand)
cannabidiol Cannabinoid (Anticonvulsant)
Type
brivaracetam Prescription
cannabidiol Prescription
Summary
brivaracetam

Brivaracetam is a medicine used to treat partial-onset seizures. It helps to reduce the number of seizures you have.

cannabidiol

Epidiolex is a medicine that contains cannabidiol. It is used to treat seizures in people with certain conditions.

What It Treats
brivaracetam

Brivaracetam is used to treat partial-onset seizures. These seizures start in one part of the brain. It can be used alone or with other seizure medicines for people 1 month and older.

cannabidiol

Epidiolex is used to treat seizures linked to Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC). It is for patients who are at least 1 year old. These conditions can cause seizures that are hard to control.

How It Works
brivaracetam

Brivaracetam binds to a protein in the brain called SV2A. This helps to reduce the electrical activity in the brain that causes seizures. It helps to stabilize nerve cells.

cannabidiol

Epidiolex contains cannabidiol, which is a substance that may affect how the brain works. It is thought to reduce seizures by acting on certain brain chemicals. The exact way it works is not fully understood.

Common Side Effects
brivaracetam
  • Feeling sleepy or tired
  • Dizziness
  • Fatigue
  • Nausea or vomiting
cannabidiol
  • Feeling sleepy
  • Decreased appetite
  • Diarrhea
  • Changes in liver blood tests
  • Feeling tired or weak
FAERS Reports
brivaracetam
  • Seizure 2,902
  • Using the medicine for a condition it's not approved for 1,036
  • The medicine is not working 896
  • Tiredness 518
  • Sleepiness 442
cannabidiol
  • Seizure 5,791
  • Using the medicine for a condition it is not approved for 2,199
  • Hospital stay 2,073
  • Using the medicine for a condition it is not approved for 1,792
  • Diarrhea 1,695
Serious Warnings
brivaracetam

Brivaracetam can cause suicidal thoughts or actions. Watch for new or worsening depression, suicidal thoughts or behavior, or unusual changes in mood. Tell your doctor right away if you have any of these symptoms. Do not stop taking brivaracetam suddenly, as this may increase your risk of seizures.

cannabidiol

Epidiolex can cause liver problems. Your doctor will check your liver before you start and during treatment. Tell your doctor right away if you feel very tired, have yellowing of the skin or eyes, dark urine, or loss of appetite. Epidiolex may also cause sleepiness or suicidal thoughts. Tell your doctor if you have any changes in mood or behavior.

Pregnancy
brivaracetam

Tell your doctor if you are pregnant or plan to become pregnant. There is a pregnancy registry for women who take brivaracetam during pregnancy. Contact the North American Antiepileptic Drug (NAAED) Pregnancy Registry at 1-888-233-2334.

cannabidiol

Tell your doctor if you are pregnant or plan to become pregnant. Epidiolex may harm your unborn baby. There are pregnancy programs to monitor outcomes, so talk to your doctor about enrolling. It is not known if Epidiolex passes into breast milk, so talk to your doctor about the best way to feed your baby if you are taking this medicine.

How to Read This brivaracetam vs cannabidiol Comparison

brivaracetam is classified in the Anticonvulsant (SV2A Ligand) drug class, while cannabidiol sits within the Cannabinoid (Anticonvulsant) class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.

Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, brivaracetam has 5,794 submissions while cannabidiol has 13,550. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.

A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between brivaracetam and cannabidiol — always consult your physician or pharmacist first.

Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.